Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Biotechnology
₹329.85
5.50 (1.70%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹3.69K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
20.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Biotechnology
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹251.95+30.9%
52W High₹419-21.3%
Current Price
₹329.85
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹263.88
Upper Circuit₹395.82
Reference Price
₹329.85
Investment Checklist
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹320.45
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
EMA(200) Crossover: Price crossed above EMA(200): Fresh bullish momentum signal.
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price below SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
38%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
337.99
EMA50
343.21
EMA200
327.53
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹345.15
₹355.65
₹364.90
₹385.92
₹395.35
Support (Below)
₹317.32
₹309.50
₹299.18
₹286.35
₹280.05
Volume Analysis
TrendINCREASING
Change+420.10%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹326.55
3% Risk₹319.95
5% Risk₹313.36
7% Risk (Custom)
₹306.76Technical Levels
1x ATR (Volatility)₹314.37
2x ATR (Swing)₹298.89
3x ATR (Trend)₹283.41
Immediate Support₹317.32
Moving Averages
EMA 9 (Short-term)₹326.67
EMA 200 (Long-term)₹327.53
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹166.8 Cr | ₹185.9 Cr | ₹184.5 Cr | ₹171.9 Cr |
| Net Profit | ₹26.5 Cr | ₹39.9 Cr | ₹43.3 Cr | ₹42.5 Cr |
| EPS | — | ₹3.57 | ₹3.87 | ₹3.80 |
| Operating Profit | ₹54.3 Cr | ₹65.3 Cr | ₹70.3 Cr | ₹69.1 Cr |
Peer Comparison
BiotechnologyPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Anthem Biosciences Limited | ₹754.70 | +0.36% | 71.6 | ₹42.39K Cr mid Cap | |
| Advanced Enzyme Technologies Limited | ₹329.85 | +1.70% | 20.9 | ₹3.69K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 23 Jul 2025 | Dividend - Rs 1.20 Per Share | DIVIDEND |
| 16 May 2025 | Interim Dividend - Rs 4 Per Share | INTERIM_DIVIDEND |
| 18 Jul 2024 | Dividend - Re 1.1 Per Share | DIVIDEND |
| 17 May 2024 | Interim Dividend - Rs 4 Per Share | INTERIM_DIVIDEND |
| 04 Aug 2023 | Dividend - Re 1 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ADVENZYMES
View AllNEWS
positive
Google News - India Markets 61d ago
Stocks to Watch Today: CMS Info Systems, Advanced Enzyme, Niva Bupa, Oberoi Realty, Bank of India, Swiggy,... - Moneycontrol.com
Stocks to Watch Today: CMS Info Systems, Advanced Enzyme, Niva Bupa, Oberoi Realty, Bank of India, Swiggy,...Moneycontrol.com
ADVENZYMESBANKINDIAC2CCMSINFOMAPMYINDIANIVABUPAOBEROIRLTYPROSTARMRICHARSYSTEMSSIGMAADVSWIGGYCapital GoodsConsumer Services
NEWS
positive
Business Standard - Markets 62d ago
Advanced Enzyme Technologies consolidated net profit rises 62.24% in the March 2026 quarter
Sales rise 21.65% to Rs 203.37 crore
ADVENZYMESHealthcare